Taiwan · Delayed Price · Currency is TWD Grape King Bio Statistics
Total Valuation
Grape King Bio has a market cap or net worth of TWD 13.23 billion. The enterprise value is 11.08 billion.
| Market Cap | 13.23B |
| Enterprise Value | 11.08B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
Grape King Bio has 148.14 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Current Share Class | 148.14M |
| Shares Outstanding | 148.14M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 11.78% |
| Owned by Institutions (%) | 18.64% |
| Float | 115.73M |
Valuation Ratios
The trailing PE ratio is 11.61.
| PE Ratio | 11.61 |
| Forward PE | n/a |
| PS Ratio | 1.31 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | 8.83 |
| P/OCF Ratio | 6.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.29, with an EV/FCF ratio of 7.40.
| EV / Earnings | 9.65 |
| EV / Sales | 1.09 |
| EV / EBITDA | 4.29 |
| EV / EBIT | 5.41 |
| EV / FCF | 7.40 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.59 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.12 |
| Interest Coverage | 441.06 |
Financial Efficiency
Return on equity (ROE) is 15.59% and return on invested capital (ROIC) is 20.56%.
| Return on Equity (ROE) | 15.59% |
| Return on Assets (ROA) | 8.51% |
| Return on Invested Capital (ROIC) | 20.56% |
| Return on Capital Employed (ROCE) | 17.21% |
| Weighted Average Cost of Capital (WACC) | 5.45% |
| Revenue Per Employee | 20.20M |
| Profits Per Employee | 2.29M |
| Employee Count | 501 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 3.18 |
Taxes
In the past 12 months, Grape King Bio has paid 417.67 million in taxes.
| Income Tax | 417.67M |
| Effective Tax Rate | 19.08% |
Stock Price Statistics
The stock price has decreased by -29.88% in the last 52 weeks. The beta is 0.23, so Grape King Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -29.88% |
| 50-Day Moving Average | 91.50 |
| 200-Day Moving Average | 112.24 |
| Relative Strength Index (RSI) | 43.69 |
| Average Volume (20 Days) | 393,393 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Grape King Bio had revenue of TWD 10.12 billion and earned 1.15 billion in profits. Earnings per share was 7.69.
| Revenue | 10.12B |
| Gross Profit | 7.44B |
| Operating Income | 2.04B |
| Pretax Income | 2.19B |
| Net Income | 1.15B |
| EBITDA | 2.50B |
| EBIT | 2.04B |
| Earnings Per Share (EPS) | 7.69 |
Balance Sheet
The company has 3.70 billion in cash and 186.69 million in debt, with a net cash position of 3.52 billion or 23.74 per share.
| Cash & Cash Equivalents | 3.70B |
| Total Debt | 186.69M |
| Net Cash | 3.52B |
| Net Cash Per Share | 23.74 |
| Equity (Book Value) | 11.60B |
| Book Value Per Share | 69.21 |
| Working Capital | 1.86B |
Cash Flow
In the last 12 months, operating cash flow was 1.99 billion and capital expenditures -493.92 million, giving a free cash flow of 1.50 billion.
| Operating Cash Flow | 1.99B |
| Capital Expenditures | -493.92M |
| Depreciation & Amortization | 462.48M |
| Net Borrowing | -74.41M |
| Free Cash Flow | 1.50B |
| FCF Per Share | 10.11 |
Margins
Gross margin is 73.47%, with operating and profit margins of 20.11% and 11.34%.
| Gross Margin | 73.47% |
| Operating Margin | 20.11% |
| Pretax Margin | 21.63% |
| Profit Margin | 11.34% |
| EBITDA Margin | 24.68% |
| EBIT Margin | 20.11% |
| FCF Margin | 14.80% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 6.65%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 6.65% |
| Dividend Growth (YoY) | -13.04% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 82.59% |
| Buyback Yield | -0.13% |
| Shareholder Yield | 6.52% |
| Earnings Yield | 8.68% |
| FCF Yield | 11.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.
| Last Split Date | Sep 15, 2005 |
| Split Type | Forward |
| Split Ratio | 1.0205 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |